Testosterone and triamcinolone 50 mg pellets recalled over metal particulate matter
FarmaKeio Outsourcing is recalling 64,924 sterile Testosterone / Triamcinolone Acetonide 50MG/10MCG pellets over the potential presence of metal particulate matter.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: Scored 3 under the risk-of-harm criterion: metal particulate in a product inserted under the skin is a hazard, and no injuries are reported.
Plain-English summary
Testosterone / Triamcinolone Acetonide, 50MG/10MCG, one sterile pellet for subcutaneous insertion, compounded by FarmaKeio Outsourcing of Southlake, Texas, is being recalled for CGMP deviations: the potential presence of metal particulate matter.
The recall covers 64,924 pellets from lots 3091, 3096 and 3097 (expiring 7 January 2026) and 3182, 3186, 3187 and 3188 (expiring 10 February 2026), carrying NDC 73693-0365-01. The product was distributed nationwide in the United States and in Antigua. The FDA has classified the recall as Class II.
The pellet is inserted under the skin, so foreign particulate matter would be introduced into the body. The enforcement record describes the potential contamination and reports no injuries.
Providers and patients holding an affected lot should stop using it and contact the firm or their prescriber.
The recalled product
- Product
- Testosterone / Triamcinolone Acetonide 50MG/10MCG, 1 PELLET (STERILE) FOR SUBCUTANEOUS INSERTION, RX ONLY, FarmaKeio Outsourcing, 920 S Kimball Ave, Ste 100, Southlake, TX 76092. NDC 73693-0365-01
- Manufacturer
- FARMAKEIO OUTSOURCING LLC
- Category
- Drug — Hormone implant
- Hazard
- particulate-matter
- metal-contamination
- cgmp-deviation
- compounded
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (9)
- Lot: 3091
- 3096
- Exp 1/7/2026
- 3097
- 3182
- 3186
- 3187
- 3188
- Exp 2/10/2026
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- ModerateQuality Choice Earwax Removal Kit Carbamide Peroxide Subpotent Drug Recall
FDA (Drugs) · 2026-07-22
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- ModerateLeader Carbamide Peroxide Earwax Removal Kit Recalled for Subpotency
FDA (Drugs) · 2026-07-22
- ModerateNystatin Cream Recall Due to Low Potency Test Results
FDA (Drugs) · 2026-07-22